BRYNOVIN (Sitagliptin Hydrochloride Oral)

**Product type:** Human Prescription Drug

**Active ingredient:** SITAGLIPTIN

**Strength:** 25 mg/mL

**Dosage form:** Solution

**Route:** Oral

**Labeler:** Azurity Pharmaceuticals, Inc.

**Marketing category:** NDA (NDA219122)

**Pharmacologic class:** Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]